BSE Live
Apr 17, 16:01Prev. Close
1693.15
Open Price
1696.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Apr 17, 15:59Prev. Close
1693.10
Open Price
1696.90
Bid Price (Qty.)
1675.50 (442)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Sun Pharmaceutical Industries (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 13,752.13 | 11,087.89 | 9,408.43 | 4,481.32 | 2,799.37 | |
| Net CashFlow From Operating Activities | 14,072.09 | 12,134.98 | 4,959.33 | 8,984.54 | 6,170.37 | |
| Net Cash Used In Investing Activities | -5,306.16 | -690.20 | -7,943.68 | -5,724.74 | 536.22 | |
| Net Cash Used From Financing Activities | -7,905.82 | -6,710.16 | 2,376.07 | -5,193.46 | -5,980.48 | |
| Foreign Exchange Gains / Losses | 123.04 | -73.99 | 157.07 | 127.43 | -129.69 | |
| Adjustments On Amalgamation Merger Demerger Others | -0.03 | 1.29 | 566.69 | 41.45 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 983.12 | 4,661.92 | 115.48 | -1,764.78 | 596.42 | |
| Cash And Cash Equivalents Begin of Year | 9,285.65 | 4,623.73 | 4,508.25 | 6,273.03 | 5,676.61 | |
| Cash And Cash Equivalents End Of Year | 10,268.77 | 9,285.65 | 4,623.73 | 4,508.25 | 6,273.03 |
17.03.2026
09.03.2026
09.03.2026
04.02.2026
Buy Sun Pharmaceutical Industries; target of Rs 1900: Prabhudas Lilladher
03.02.2026
Sun Pharma Consolidated December 2025 Net Sales at Rs 15,520.54 crore, up 13.49% Y-o-Y
03.02.2026
Sun Pharma Standalone December 2025 Net Sales at Rs 5,687.77 crore, down 8.14% Y-o-Y
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
01.08.2025
Sun Pharma Consolidated June 2025 Net Sales at Rs 13,851.40 crore, up 9.47% Y-o-Y
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth